Cell-Free DNA (cfDNA) Testing Market Size, Share, Statistics, Trends, Business Opportunities, Key Players, Drivers and Restraint Research Report by 2027

The latest report titled Global Cell-Free DNA Testing Market by Emergen Research involves meticulous research on the global Cell-Free DNA Testing business space, expanding on the latest industry trends, worldwide market growth, market size & share, key drivers and opportunities, constraining factors, product segmentation, cost structure, market volume, competitive terrain, product portfolios and specifications, and company profiles. The global Cell-Free DNA (cfDNA) testing market is expected to grow significantly during the forecast period due to the increased incidence of cancers, rising prevalence of chromosome abnormalities in babies due to an increasing number of late pregnancy, and growing demand for non-invasive testing procedures.

Besides, the increasing investments by governments to implement advanced therapeutic technology in hospitals is also expected to boost the market during the forecast period.

Get Download Pdf Sample Copy of this Report@ https://www.emergenresearch.com/request-sample/156

Key Highlights From The Report

  • In August 2019, Agilent Technologies Inc. announced the acquisition of a leading manufacturer of innovative healthcare equipment, BioTek Instruments, Inc. This acquisition will expand Agilent’s product portfolio and its presence in North America.
  • The MPSS technology segment is anticipated to dominate the global market with a CAGR of 26.7%, owing to the advantage of producing a measurable profile of gene expression in cells or tissues.
  • The gynecology segment is anticipated to lead the market during the forecasted period, as the cell-free DNA approach is being used to detect genetic issues of baby and to diagnose pregnancy complications such as pregnancy loss.
  • Key participants include Sequenom, Inc., Quest Diagnostics, Illumina Inc., Agilent Technologies, Inc., Guardant Health, Inc., Biodesix, Inc., Allenex AB, Roche Holdings AG, Biocept, Inc., and CareDx, Inc., among others.

Market Segmentation:

The report categorizes the market into different key segments based on types and applications, along with key regional segmentation. The report offers insights into the segment expected to garner traction during the forecast period, and the region expected to dominate the market in the coming years.

Emergen Research has segmented the global Cell-Free DNA (cfDNA) Testing Market on the basis of type, technology, application, and region:

  • Type Outlook (Revenue, USD Billion; 2017-2027)
    • Cell-free fetal DNA (NIPT)
    • Circulating tumor DNA
    • Donor-derived cell-free DNA
  • Technology Outlook (Revenue, USD Billion; 2017-2027)
    • MPSS
    • t-MPS
    • SNP
    • Others
  • Application Outlook (Revenue, USD Billion; 2017-2027)
    • Transplantation
    • Gynecology
    • Oncology

The Global Cell-Free DNA Testing Market can be geographically bifurcated on the basis of regional demand, output, and estimated revenue share. The most prominent regions dictating the global market include:

  • North America (U.S., Canada, Mexico)
  • Europe (U.K., Germany, France, Italy)
  • Asia Pacific (China, Japan, India, Korea)
  • Latin America (Brazil, Argentina, Ecuador, Chile)
  • Middle East Africa (Egypt, Turkey, Saudi Arabia, Iran)

Request customization of the report @ https://www.emergenresearch.com/request-for-customization/156

The following are the main reasons to buy the Global Cell-Free DNA Testing Market report:

  1. The latest report closely evaluates the overall market size and infers on various aspects, such as the current business trends, market share, product offerings, and product share.
  2. It offers a detailed account of the end-use applications of the products & services offered by this industry.
  3. It offers an insightful analysis of the various regional segments of the market that are projected to witness enormous growth over the forecast period.
  4. Furthermore, the report covers the latest developments taking place in the market and effective business strategies implemented by the leading market rivals.

Table Of Content:

Chapter 1. Methodology & Sources
1.1. Market Definition
1.2. Research Scope
1.3. Methodology
1.4. Research Sources
1.4.1. Primary
1.4.2. Secondary
1.4.3. Paid Sources
1.5. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2019-2027
Chapter 3. Key Insights
Chapter 4. Cell-Free DNA (cfDNA) testing Market Segmentation & Impact Analysis
4.1. Cell-Free DNA (cfDNA) testing Market Segmentation Analysis
4.2. Industrial Outlook
4.2.1. Market indicators analysis
4.2.2. Market drivers analysis
4.2.2.1. Increasing incidents of chronic disease
4.2.2.2. Growing demand for non-invasive testing methodologies
4.2.3. Market restraints analysis
4.2.3.1. Lack of standardization
4.2.3.2. Unfavorable legal and regulatory rules
4.3. Technological Insights
4.4. Regulatory Framework
4.5. Porter’s Five Forces Analysis
4.6. Competitive Metric Space Analysis
4.7. Price trend Analysis
4.8. Covid-19 Impact Analysis

Chapter 5. Cell-Free DNA (cfDNA) testing Market By Type Insights & Trends, Revenue (USD Billion)
5.1. Type Dynamics & Market Share, 2019 & 2027
5.1.1. Cell-free fetal DNA (NIPT)
5.1.2. Circulating tumor DNA
5.1.3. Donor-derived cell-free DNA

READ MORE…!

To Visit Full Report & Table of Contents Cell-Free DNA Testing Market@ https://www.emergenresearch.com/industry-report/cell-free-dna-market

Thank you for reading our report. Please get in touch with us if you wish to request a customization of the report. Our team will ensure you get a report well-suited for your needs.

Related Articles

Back to top button